Advertisement
PP:13| Volume 35, SUPPLEMENT 1, S31-S32, October 2021

PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS IN CARDIAC SURGERY. WHAT SHOULD WE KNOW?

      Introduction

      Perioperative antibiotic prophylaxis has proved to reduce the number of postoperative infections. In cardiac surgery, the infections in the surgical site are found to be around 0.4-4%. The most common bacterias causing surgical site infections in cardiac surgery are gram-positive.
      Our aim in to guide the reader in the decision of choosing the most adequate Perioperative Antibiotic Prophylaxis in each patient according to their characteristics and their environment.

      Methods

      The most recent bibliography was reviewed searching the most common antibiotics used in perioperative Antibiotic Prophylaxis in cardiac surgery. A bibliographic search was carried out in the PubMed-MEDLINE database. A peer review was performed and a total of 4 references of more than 30 were selected.

      Results

      There is no difference in the Surgical Site Infections between the use of 1st generation of Cephalosporin or Glycopeptides such as Vancomycin or Teicoplanin. On the other hand, 1st generation of Cephalosporin reduces the incidence of infections produced by Staphylococcus. Nevertheless, Glycopeptides are better at avoiding infection produced by Staphylococcus and Enterococcus resistant than Cephalosporin.

      Discussion

      Choosing Perioperative Antibiotic Prophylaxis must be individualized according to the bacterial flora in the environment, the different characteristics of the patients, and the type of cardiac surgery. Also, a high incidence of Staphylococcus Aureus methicillin-resistant must receive prophylaxis with Vancomycin and a second antibiotic should be considered.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect